Qiagen is the world's leading provider of sample and assays technologies- tools that enable the handling, processing and preparation as well as the molecular analysis and testing of any biological sample.

We have developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. We also supply diagnostic kits, tests, and assays for human and veterinary molecular diagnostics.

Our products are sold to academic research markets, and to leading pharmaceutical and biotechnology companies as well as to diagnostics laboratories. QIAGEN also provides purification and testing solutions to applied testing markets such as forensics, animal or food testing, and pharmaceutical process control.

We employ more than 2,000 people worldwide. QIAGEN products are sold through a dedicated sales force and a global network of distributors in more than 40 countries. Our close contact with customers keeps us on the cutting edge of new technologies and identifies market needs that feed into our product development engine.

Innovation at QIAGEN

Qiagen Hilden

Discoveries in molecular biology over the last 50 years have changed our lives and resulted in significant advances in modern medicine. Our every day vocabularies have been expanded with terms such as DNA, molecular diagnostics and personalized medicine. Powerful, new tools of molecular biology give researchers new and vast opportunities to understand life's processes. One outcome of this research is vital information that helps to cure and prevent diseases.

But innovation doesn't occur in isolation. QIAGEN have always believed that the interaction with customers and responding to their needs result in high levels of creativity. Furthermore, many and important collaborations with academia, research institutes and leading companies in the pharmaceutical and diagnostics industries support our internal resources. Each collaboration provides vital resources and expertise that we are able to leverage during the innovation process, often resulting in first- of- a- kind product solutions.

The recent advances made in nanotechnology look very promising for life science applications. We believe that the combination of nanotechnology and biotechnology can offer new perspectives and solutions on existing scientific and technological issues. Nanobiotechnology is beginning to generate substantial new insights into how biological systems function, and likewise, the nanobiotechnology will lead to the design of entirely new devices, systems and tools to be used in life sciences applications.

Qiagen and Nano2Life

The possibility to be integrated as a associated partner in the Nano2life network offers QIAGEN the opportunity to be involved in sharing expertise, knowledge and ideas with high level researchers.

Through the informal contact, made possible by the meetings organised in Nano2life, chances arise to set fruitful collaborations between nanotechnology and biotechnology. In fact, a national funded project has been successfully set up between a Nano2Life member and QIAGEN.

To that respect, together we bring Nano to Life!